As antibiotics shortages are seen around the world, the International Generic and Biosimilar Medicines Association has offered advice and action to address the situation, while the US Association for Accessible Medicines has countered suggestions that supply issues are due to a “broken generic drug market.”
Industry Speaks Out On Global Antibiotics Shortages
IGBA And AAM Offer Recommendations To Respond To International Supply Issues
Responding to shortages of antibiotics seen around the world, the IGBA has insisted that the generics industry is working to address spikes in demand and has set out a series of recommendations to mitigate the situation. Meanwhile, US association the AAM has countered suggestions that supply issues are due to a “broken generic drug market.”
